Logan Capital Management Inc Novartis Ag Transaction History

Logan Capital Management Inc

  • $2.28 Billion
  • Q4 2024

A detailed history of Logan Capital Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Logan Capital Management Inc holds 41,381 shares of NVS stock, worth $4.36 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
41,381
Previous 40,836 1.33%
Holding current value
$4.36 Million
Previous $4.7 Million 14.27%
% of portfolio
0.18%
Previous 0.2%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$96.78 - $117.18 $52,745 - $63,863
545 Added 1.33%
41,381 $4.03 Million
Q3 2024

Dec 06, 2024
BUY
$106.13 - $120.89 $180,633 - $205,754
1,702 Added 4.35%
40,836 $4.7 Million
Q2 2024

Aug 14, 2024
SELL
$92.57 - $107.37 $140,798 - $163,309
-1,521 Reduced 3.74%
39,134 $4.17 Million
Q1 2024

May 13, 2024
BUY
$95.27 - $108.47 $496,166 - $564,911
5,208 Added 14.69%
40,655 $3.93 Million
Q4 2023

Feb 14, 2024
BUY
$92.27 - $101.54 $144,679 - $159,214
1,568 Added 4.63%
35,447 $3.58 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $418,990 - $464,989
-4,423 Reduced 11.55%
33,879 $3.45 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $97,701 - $110,784
-1,056 Reduced 2.68%
38,302 $3.87 Million
Q1 2023

May 12, 2023
BUY
$80.03 - $92.81 $9,363 - $10,858
117 Added 0.3%
39,358 $3.62 Million
Q4 2022

Feb 14, 2023
BUY
$75.55 - $92.52 $113,929 - $139,520
1,508 Added 4.0%
39,241 $3.56 Million
Q3 2022

Nov 14, 2022
BUY
$74.61 - $87.26 $240,990 - $281,849
3,230 Added 9.36%
37,733 $2.87 Million
Q2 2022

Aug 11, 2022
BUY
$80.52 - $93.75 $360,890 - $420,187
4,482 Added 14.93%
34,503 $2.92 Million
Q1 2022

May 16, 2022
BUY
$80.11 - $90.62 $145,960 - $165,109
1,822 Added 6.46%
30,021 $2.63 Million
Q4 2021

Feb 14, 2022
BUY
$79.7 - $88.13 $340,079 - $376,050
4,267 Added 17.83%
28,199 $2.47 Million
Q3 2021

Nov 12, 2021
SELL
$81.78 - $95.14 $7,523 - $8,752
-92 Reduced 0.38%
23,932 $1.96 Million
Q2 2021

Aug 17, 2021
BUY
$85.24 - $94.15 $283,423 - $313,048
3,325 Added 16.06%
24,024 $2.19 Million
Q1 2021

May 14, 2021
BUY
$83.5 - $98.47 $45,257 - $53,370
542 Added 2.69%
20,699 $1.77 Million
Q4 2020

Feb 12, 2021
SELL
$78.07 - $94.43 $66,047 - $79,887
-846 Reduced 4.03%
20,157 $1.9 Million
Q3 2020

Nov 13, 2020
BUY
$82.14 - $91.0 $106,782 - $118,300
1,300 Added 6.6%
21,003 $1.83 Million
Q2 2020

Aug 14, 2020
BUY
$80.93 - $91.1 $64,258 - $72,333
794 Added 4.2%
19,703 $1.72 Million
Q1 2020

May 14, 2020
BUY
$70.67 - $99.01 $102,047 - $142,970
1,444 Added 8.27%
18,909 $1.56 Million
Q4 2019

Feb 10, 2020
BUY
$84.35 - $95.37 $49,007 - $55,409
581 Added 3.44%
17,465 $1.65 Million
Q3 2019

Nov 14, 2019
BUY
$85.54 - $94.26 $131,646 - $145,066
1,539 Added 10.03%
16,884 $1.47 Million
Q2 2019

Jul 24, 2019
BUY
$75.4 - $92.8 $94,325 - $116,092
1,251 Added 8.88%
15,345 $1.4 Million
Q1 2019

May 15, 2019
SELL
$75.32 - $86.15 $95,355 - $109,065
-1,266 Reduced 8.24%
14,094 $1.36 Million
Q4 2018

Feb 14, 2019
BUY
$73.66 - $82.02 $44,564 - $49,622
605 Added 4.1%
15,360 $1.32 Million
Q3 2018

Nov 13, 2018
BUY
$66.94 - $77.43 $37,419 - $43,283
559 Added 3.94%
14,755 $1.27 Million
Q2 2018

Aug 14, 2018
BUY
$64.91 - $73.36 $32,844 - $37,120
506 Added 3.7%
14,196 $1.07 Million
Q1 2018

May 14, 2018
SELL
$70.39 - $84.15 $51,455 - $61,513
-731 Reduced 5.07%
13,690 $1.11 Million
Q4 2017

Feb 12, 2018
BUY
$72.33 - $77.64 $31,174 - $33,462
431 Added 3.08%
14,421 $1.21 Million
Q3 2017

Nov 14, 2017
BUY
$74.14 - $77.27 $83,704 - $87,237
1,129 Added 8.78%
13,990 $1.2 Million
Q2 2017

Aug 14, 2017
BUY
N/A
12,861
12,861 $1.07 Million

Others Institutions Holding NVS

# of Institutions
1,468
Shares Held
134M
Call Options Held
1.4M
Put Options Held
1.61M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $227B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Logan Capital Management Inc Portfolio

Follow Logan Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logan Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Logan Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email